- European Commission Approves Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis BioSpace
- Vertex Pharmaceuticals Says EU Approves Kaftrio Label Expansion in Cystic Fibrosis MarketScreener
- European Commission Expands Approval for Vertex’s Kaftrio (VRTX) GuruFocus
- Vertex Pharma wins EU nod to expand cystic fibrosis drug label Seeking Alpha
- Vertex Gains European Approval For Expanded Use Of KAFTRIO In Treating Cystic Fibrosis Nasdaq
